IMDX Competitors & Alternatives
Compare Insight Molecular Diagnostics Inc. with similar stocks in the same industry
Diagnostics & Research
IMDX
Main Stock$4.34
Tradestie Score
51
Market Cap
$94.16M
Revenue Growth
-0.5%
Analyst Upside
+92.0%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$16.98
|
$1.13B | - | 40 | Compare |
|
CDNA
CareDx, Inc.
|
$48.61
|
$798.40M | 22.4 | 35 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$19.90
|
$719.31M | - | 53 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$34.20
|
$667.77M | - | 33 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$18.38
|
$612.76M | - | 44 | Compare |
|
LCTX
Lineage Cell Therapeutics, Inc.
|
$1.08
|
$385.92M | - | 63 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$33.26
|
$62.81M | - | 44 | Compare |
|
AKTX
Akari Therapeutics plc ADR (0.01 USD)
|
$7.85
|
$31.97M | - | 51 | Compare |
|
SYBX
Synlogic, Inc. Common Stock
|
$0.56
|
$19.89M | - | 42 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$3.59
|
$4.78M | - | 30 | Compare |
More IMDX Analysis
Data updated: Aug 22, 2026 | Industry: Diagnostics & Research (SIC 2835)
39 stocks in this industry